NLRP3 and breast carcinoma: Numerous studies have reported the capacity of anti-tumor drugs to stimulate the caspase-1-dependent cell death of tumor cells; however, the role of the NLRP3 inflammasome and pyroptosis in the breast cancer context is still ambiguous and requires in-depth molecular studies for a full understanding.